Literature DB >> 25696145

Evaluation of antiatherosclerotic drugs by Raman spectroscopy.

S W F van de Poll, A van der Laarse.   

Abstract

Year:  2003        PMID： 25696145      PMCID： PMC2499835     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


× No keyword cloud information.
  10 in total

1.  Impaired cardiomyocyte relaxation and diastolic function in transgenic mice expressing slow skeletal troponin I in the heart.

Authors:  R C Fentzke; S H Buck; J R Patel; H Lin; B M Wolska; M O Stojanovic; A F Martin; R J Solaro; R L Moss; J M Leiden
Journal:  J Physiol       Date:  1999-05-15       Impact factor: 5.182

2.  Quantitative assessment of aortic atherosclerosis in APOE*3 Leiden transgenic mice and its relationship to serum cholesterol exposure.

Authors:  P H Groot; B J van Vlijmen; G M Benson; M H Hofker; R Schiffelers; M Vidgeon-Hart; L M Havekes
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-08       Impact factor: 8.311

3.  Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice.

Authors:  R K Tangirala; E M Rubin; W Palinski
Journal:  J Lipid Res       Date:  1995-11       Impact factor: 5.922

Review 4.  Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995.

Authors:  M J Davies
Journal:  Circulation       Date:  1996-10-15       Impact factor: 29.690

Review 5.  Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization.

Authors:  P Libby; U Schoenbeck; F Mach; A P Selwyn; P Ganz
Journal:  Am J Med       Date:  1998-02-23       Impact factor: 4.965

6.  Progression and regression of atherosclerosis in APOE3-Leiden transgenic mice: an immunohistochemical study.

Authors:  M J Gijbels; M van der Cammen; L J van der Laan; J J Emeis; L M Havekes; M H Hofker; G Kraal
Journal:  Atherosclerosis       Date:  1999-03       Impact factor: 5.162

7.  Determination of human coronary artery composition by Raman spectroscopy.

Authors:  J F Brennan; T J Römer; R S Lees; A M Tercyak; J R Kramer; M S Feld
Journal:  Circulation       Date:  1997-07-01       Impact factor: 29.690

8.  Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.

Authors:  B J van Vlijmen; A M van den Maagdenberg; M J Gijbels; H van der Boom; H HogenEsch; R R Frants; M H Hofker; L M Havekes
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

Review 9.  Coronary artery disease regression. Convincing evidence for the benefit of aggressive lipoprotein management.

Authors:  H R Superko; R M Krauss
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690

10.  Evidence for a synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis in symptomatic patients with normal to moderately raised cholesterol levels. The REGRESS Study Group.

Authors:  J W Jukema; A H Zwinderman; A J van Boven; J H Reiber; A Van der Laarse; K I Lie; A V Bruschke
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-03       Impact factor: 8.311
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.